HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane).

Abstract
Lymphoid neogenesis is associated with antibody-mediated autoimmune diseases such as Sjogren's syndrome and rheumatoid arthritis. Although systemic lupus erythematosus is the prototypical B-cell-mediated autoimmune disease, the role of lymphoid neogenesis in its pathogenesis is unknown. Intraperitoneal injection of 2,6,10,14-tetramethyl-pentadecane (TMPD, pristane) or mineral oil causes lipogranuloma formation in mice, but only TMPD-treated mice develop lupus. We report that lipogranulomas are a form of lymphoid neogenesis. Immunoperoxidase staining of lipogranulomas revealed B cells, CD4(+) T cells, and dendritic cells and in some cases organization into T- and B-cell zones. Lipogranulomas also expressed the lymphoid chemokines CCL21, CCL19, CXCL13, CXCL12, and CCL22. Expression of the type I interferon (IFN-I)-inducible genes Mx1, IRF7, IP-10, and ISG-15 was greatly increased in TMPD- versus mineral oil-induced lipogranulomas. Dendritic cells from TMPD lipogranulomas underwent activation/maturation with high CD86 and interleukin-12 expression. Magnetic bead depletion of dendritic cells markedly diminished IFN-inducible gene (Mx1) expression. We conclude that TMPD-induced lupus is associated with the formation of ectopic lymphoid tissue containing activated dendritic cells producing IFN-I and interleukin-12. In view of the increased IFN-I production in systemic lupus erythematosus, these studies suggest that IFN-I from ectopic lymphoid tissue could play a role in the pathogenesis of experimental lupus in mice.
AuthorsDina C Nacionales, Kindra M Kelly, Pui Y Lee, Haoyang Zhuang, Yi Li, Jason S Weinstein, Eric Sobel, Yoshiki Kuroda, Jun Akaogi, Minoru Satoh, Westley H Reeves
JournalThe American journal of pathology (Am J Pathol) Vol. 168 Issue 4 Pg. 1227-40 (Apr 2006) ISSN: 0002-9440 [Print] United States
PMID16565497 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemokine CXCL10
  • Chemokines
  • Chemokines, CXC
  • Cytokines
  • G1p2 protein, mouse
  • Interferon Regulatory Factor-7
  • Interferon Type I
  • Irf7 protein, mouse
  • Mx1 protein, mouse
  • Myxovirus Resistance Proteins
  • Terpenes
  • Ubiquitins
  • Interleukin-12
  • pristane
  • Mineral Oil
  • GTP-Binding Proteins
Topics
  • Animals
  • Cell Line
  • Chemokine CXCL10
  • Chemokines (biosynthesis)
  • Chemokines, CXC (biosynthesis)
  • Choristoma (chemically induced, metabolism, pathology)
  • Cytokines (biosynthesis)
  • Dendritic Cells (metabolism)
  • Female
  • GTP-Binding Proteins (biosynthesis)
  • Granuloma (chemically induced, metabolism, pathology)
  • Interferon Regulatory Factor-7 (biosynthesis)
  • Interferon Type I (biosynthesis)
  • Interleukin-12 (biosynthesis)
  • Lupus Erythematosus, Systemic (chemically induced, pathology)
  • Lymphoid Tissue (drug effects, metabolism, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Mineral Oil
  • Myxovirus Resistance Proteins
  • Peritoneum
  • Terpenes
  • Ubiquitins (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: